|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES: | |||||
| Consolidated net income (loss) | |||||
| Adjustments to reconcile net income to net cash provided by (used in) operating activities: | |||||
| Gains on originated mortgage servicing rights | |||||
| Depreciation and amortization | |||||
| Lease impairment | |||||
| Nasdaq Earn-out recognition | |||||
| Provision (benefit) for credit losses on the financial guarantee liability | |||||
| Provision (reversal) for doubtful accounts | |||||
| Equity-based compensation and allocation of net income to limited partnership units and FPUs | |||||
| Employee loan amortization and other non-cash compensation expense | |||||
| Deferred tax provision (benefit) | |||||
| Non-cash changes in acquisition related earn-outs | |||||
| Unrealized (gains) on loans held for sale | |||||
| Unrealized (gains) on investments | |||||
| Income from an equity method investment | |||||
| Realized losses on marketable securities | |||||
| Unrealized losses on marketable securities | |||||
| Unrealized losses (gains) on non-marketable investments | |||||
| Change in valuation of derivative asset | |||||
| Loan originations—loans held for sale | |||||
| Loan sales—loans held for sale | |||||
| Other | |||||
| Consolidated net income (loss), adjusted for non-cash and non-operating items | |||||
| Changes in operating assets and liabilities: | |||||
| Receivables, net | |||||
| Loans, forgivable loans and other receivables from employees and partners, net | |||||
| Right-of-use assets | |||||
| Receivable from related parties | |||||
| Other assets | |||||
| Accrued compensation | |||||
| Right-of-use liability | |||||
| Accounts payable, accrued expenses and other liabilities | |||||
| Payables to related parties | |||||
| Net cash provided by (used in) operating activities | |||||
| CASH FLOWS FROM INVESTING ACTIVITIES: | |||||
| Payments for acquisitions, net of cash acquired and proceeds from divestitures | |||||
| Proceeds from the sale of marketable securities | |||||
| Proceeds from the exercise of redemption option | |||||
| Purchase of marketable securities | |||||
| Purchase of non-marketable investments | |||||
| Payments for intangible assets | |||||
| Purchases of fixed assets | |||||
| Purchase of restricted short-term investments | |||||
| Proceeds from maturity of restricted short-term investments | |||||
| Net cash provided by (used in) investing activities | |||||
| CASH FLOWS FROM FINANCING ACTIVITIES: | |||||
| Proceeds from warehouse facilities | |||||
| Principal payments on warehouse facilities | |||||
| Proceeds from the sale of limited partnership interests | |||||
| Borrowing of debt | |||||
| Repayment of debt | |||||
| Repurchase agreements and securities loaned | |||||
| Redemption and repurchase of limited partnership interests | |||||
| Purchase of limited partnership interests | |||||
| Treasury stock repurchases | |||||
| Earnings and tax distributions to limited partnership interests and other noncontrolling interests | |||||
| Dividends to stockholders | |||||
| Payments on acquisition earn-outs | |||||
| Deferred financing costs | |||||
| Net cash provided by (used in) financing activities | |||||
| Net increase (decrease) in cash and cash equivalents and restricted cash | |||||
| Cash and cash equivalents and restricted cash at beginning of period | |||||
| Cash and cash equivalents and restricted cash at end of period | |||||
| Supplemental disclosures of cash flow information: | |||||
| Cash paid during the period for: | |||||
| Interest | |||||
| Taxes | |||||
| Supplemental disclosure of non-cash operating, investing and financing activities: | |||||
| Right-of-use assets and liabilities | |||||
| Deferred tax asset | |||||
| Tax Receivable Agreement liability | |||||
Loading...